147 related articles for article (PubMed ID: 38072401)
1. Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea.
Ha HI; Kim JH; Lim J; Song YJ; Won YJ; Lim MC
J Gynecol Oncol; 2024 Jan; 35(1):e31. PubMed ID: 38072401
[TBL] [Abstract][Full Text] [Related]
2. Incidence and survival rates of primary uterine carcinosarcoma in Korea: a National Cancer Registry study.
Kim SI; Kim JH; Lee C; Ha J; Jung KW; Lim MC
J Gynecol Oncol; 2023 Jan; 34(1):e9. PubMed ID: 36366811
[TBL] [Abstract][Full Text] [Related]
3. Incidence and treatment outcomes of ovarian sarcoma compared to epithelial ovarian cancer from the national cancer registry.
Ha HI; Cho SH; Lim J; Lee YJ; Yoo CW; Won YJ; Lim MC
Gynecol Oncol; 2021 Dec; 163(3):506-510. PubMed ID: 34602286
[TBL] [Abstract][Full Text] [Related]
4. Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012.
Kim SI; Lim MC; Lim J; Won YJ; Seo SS; Kang S; Park SY
J Gynecol Oncol; 2016 Jan; 27(1):e5. PubMed ID: 26463436
[TBL] [Abstract][Full Text] [Related]
5. Incidence and treatment outcomes of uterine cervical cancer in Korea 1999-2018 from the national cancer registry.
Suh DH; Ha HI; Lee YJ; Lim J; Won YJ; Lim MC
J Gynecol Oncol; 2023 Mar; 34(2):e39. PubMed ID: 36731896
[TBL] [Abstract][Full Text] [Related]
6. Trends in the Incidence and Survival Rates of Primary Ovarian Clear Cell Carcinoma Compared to Ovarian Serous Carcinoma in Korea.
Kim SI; Ha HI; Eoh KJ; Lim J; Won YJ; Lim MC
Front Oncol; 2022; 12():874037. PubMed ID: 35463304
[TBL] [Abstract][Full Text] [Related]
7. Increased incidence with improved survival of gynecologic carcinosarcoma: A population-based study.
Salman L; Brudner Y; Silverman BG; Hallak M; Bruchim I
Eur J Obstet Gynecol Reprod Biol; 2021 Nov; 266():106-110. PubMed ID: 34624737
[TBL] [Abstract][Full Text] [Related]
8. Carcinosarcoma of the ovary.
Silasi DA; Illuzzi JL; Kelly MG; Rutherford TJ; Mor G; Azodi M; Schwartz PE
Int J Gynecol Cancer; 2008; 18(1):22-9. PubMed ID: 17451459
[TBL] [Abstract][Full Text] [Related]
9. Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999-2017.
Park M; Lim J; Lee JA; Park HJ; Park BK; Lim MC; Park SY; Won YJ
Gynecol Oncol; 2021 Oct; 163(1):79-84. PubMed ID: 34392955
[TBL] [Abstract][Full Text] [Related]
10. Cancer incidence and survival among adolescents and young adults in Korea.
Moon EK; Park HJ; Oh CM; Jung KW; Shin HY; Park BK; Won YJ
PLoS One; 2014; 9(5):e96088. PubMed ID: 24789075
[TBL] [Abstract][Full Text] [Related]
11. Carcinosarcoma of the ovary: incidence, prognosis, treatment and survival of patients.
Chang J; Sharpe JC; A'Hern RP; Fisher C; Blake P; Shepherd J; Gore ME
Ann Oncol; 1995 Oct; 6(8):755-8. PubMed ID: 8589011
[TBL] [Abstract][Full Text] [Related]
12. Current Trends in the Incidence and Survival Rate of Urological Cancers in Korea.
Joung JY; Lim J; Oh CM; Jung KW; Cho H; Kim SH; Seo HK; Park WS; Chung J; Lee KH; Won YJ
Cancer Res Treat; 2017 Jul; 49(3):607-615. PubMed ID: 27658388
[TBL] [Abstract][Full Text] [Related]
13. Trends in incidence and survival of esophageal cancer in Korea: Analysis of the Korea Central Cancer Registry Database.
Shin A; Won YJ; Jung HK; Kong HJ; Jung KW; Oh CM; Choe S; Lee J
J Gastroenterol Hepatol; 2018 Dec; 33(12):1961-1968. PubMed ID: 29802647
[TBL] [Abstract][Full Text] [Related]
14. Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999-2015.
Lim MC; Won YJ; Ko MJ; Kim M; Shim SH; Suh DH; Kim JW
J Gynecol Oncol; 2019 Jan; 30(1):e38. PubMed ID: 30574686
[TBL] [Abstract][Full Text] [Related]
15. Radical surgical cytoreduction in the treatment of ovarian carcinosarcoma.
Doo DW; Erickson BK; Arend RC; Conner MG; Huh WK; Leath CA
Gynecol Oncol; 2014 May; 133(2):234-7. PubMed ID: 24631447
[TBL] [Abstract][Full Text] [Related]
16. Incidence and survival of gynecologic cancer including cervical, uterine, ovarian, vaginal, vulvar cancer and gestational trophoblastic neoplasia in Korea, 1999-2019: Korea Central Cancer Registry.
Yun BS; Park EH; Ha J; Lee JY; Lee KH; Lee TS; Lee KJ; Kim YJ; Jung KW; Roh JW
Obstet Gynecol Sci; 2023 Nov; 66(6):545-561. PubMed ID: 37953552
[TBL] [Abstract][Full Text] [Related]
17. Second Primary Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers after Breast Cancer Diagnosis: Korea Central Cancer Registry.
Ha HI; Lee EG; Lim J; Jung SY; Chang YJ; Won YJ; Lim MC
Cancer Res Treat; 2021 Apr; 53(2):541-548. PubMed ID: 33211942
[TBL] [Abstract][Full Text] [Related]
18. Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes.
Garg G; Shah JP; Kumar S; Bryant CS; Munkarah A; Morris RT
Int J Gynecol Cancer; 2010 Jul; 20(5):888-94. PubMed ID: 20606539
[TBL] [Abstract][Full Text] [Related]
19. Carcinosarcoma of the ovary: a case-control study.
Rauh-Hain JA; Growdon WB; Rodriguez N; Goodman AK; Boruta DM; Schorge JO; Horowitz NS; del Carmen MG
Gynecol Oncol; 2011 Jun; 121(3):477-81. PubMed ID: 21420726
[TBL] [Abstract][Full Text] [Related]
20. Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage.
Peres LC; Cushing-Haugen KL; Köbel M; Harris HR; Berchuck A; Rossing MA; Schildkraut JM; Doherty JA
J Natl Cancer Inst; 2019 Jan; 111(1):60-68. PubMed ID: 29718305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
